Puma forecasts weak growth as geopolitical tensions weigh on sales
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Puma has warned that
Who wants to buy a Tesla?
[ad_1] Plus, the private equity group going after Walgreens Boots and the uncertain future for Seven & i as it gets a new boss [ad_2]
Lagarde says ‘impossible’ for ECB to always meet inflation target
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. European Central Bank president
Donald Trump Jr: championing the Maga economy
[ad_1] ESG and DEI are out as the US president’s son makes lucrative investments that align with his father’s vision of America [ad_2] Source link
Capital Group wades into active ETF model portfolio market
[ad_1] Latest news on ETFs Visit our ETF Hub to find out more and to explore our in-depth data and comparison tools The world’s largest
PwC cuts record number of UK partners and halts tech apprenticeship scheme
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. A record number of
Farewell Mister Haffmann theatre review — Nazi occupation play mixes comedy and dread
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. “It’s farcical,” says Isabelle
The ‘freedom railway’: China’s new plan to take on the US in Africa
[ad_1] Tazara project showcases Beijing’s leaner approach to overseas development just as western aid appears to retreat [ad_2] Source link
Northvolt files for bankruptcy in Sweden
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Battery maker Northvolt has
Roche signs biggest-ever obesity drug deal
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Roche has signed the
